Rogler, Gerhard
Article History
First Online: 5 August 2014
Competing interests
: G.R. has acted as a consultant to Abbott, Augurix, Calypso, Essex/MSD, FALK, Genentech, Novartis, Roche, Tillotts Pharma, UCB and Vifor Pharma. G.R. has received speaker's honoraria from Abbott, FALK, MSD, Phadia, Tillotts Pharma, UCB and Vifor Pharma, and received educational grants and research grants from Abbott, Ardeypharm, Essex/MSD, FALK, Flamentera AG, Novartis, Roche, Tillotts Pharma, UCB and Zeller.